Man Group’s Natus Medical Inc NTUS Stock Holding History

Man Group’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Hold	0	–	–	–	357
2021 Q3	–	Sell	-9,403	Closed	-$244K	–	2178
2021 Q2	$244K	Sell	9,403 -2,565	-21%	-$69.8K	﹤0.01%	1743
2021 Q1	$306K	Sell	11,968 -73,693	-86%	-$1.89M	﹤0.01%	1623
2020 Q4	$1.72M	Buy	85,661 +19,339	+29%	+$379K	0.01%	1254
2020 Q3	$1.14M	Buy	66,322 +13,475	+25%	+$255K	﹤0.01%	1342
2020 Q2	$1.15M	Buy	52,847 +3,377	+7%	+$77.3K	0.01%	1239
2020 Q1	$1.14M	Sell	49,470 -11,135	-18%	-$324K	0.01%	1078
2019 Q4	$2M	Buy	+60,605	New	+$1.94M	0.01%	1331
2018 Q4	–	Sell	-22,943	Closed	-$818K	–	2187
2018 Q3	$818K	Sell	22,943 -679	-3%	-$24K	﹤0.01%	1729
2018 Q2	$815K	Buy	+23,622	New	+$828K	﹤0.01%	1665

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MAM

Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's NTUS Position: Q2 2022 in Review

Man Group held its Natus Medical Inc (NTUS) position steady in Q2 2022 at 0 shares worth $15.8M. The position accounts for 0.07% of the portfolio, ranked #357.

Man Group first reported a position in NTUS in Q2 2018 and has held it in 9 quarters since. The position peaked at $2M in Q4 2019. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

Man Group held 0 shares of Natus Medical Inc worth $15.8M as of Q2 2022.
Man Group left its Natus Medical Inc share count unchanged in Q2 2022.
Natus Medical Inc made up 0.07% of Man Group's portfolio in Q2 2022, its #357 holding.
Man Group first reported a position in Natus Medical Inc in Q2 2018 and has held it in 9 quarters since.
Man Group's Natus Medical Inc position peaked at $2M in Q4 2019.
186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.